How does national legislation in different EU member states compare and how effective is the adding of new psychoactive substances (NPS) to the existing schedules of drug laws versus legislative experimentation designing new schedules or applying controls under medicines or consumer protection regulations?
Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.
Uruguay’s senate voted today (10 December) to approve the world’s first national legal framework regulating the cultivation, trade and consumption of cannabis for medical, industrial as well as recreational purposes.
U.S. drug control officials have denounced Dutch drug policy as if it were the devil himself. One former U.S. Drug Czar said "you can't walk down the street in Amsterdam without tripping over junkies." In the Summer of 1998, however, one such denouncement turned into a small scandal. The first part of this chapter examines this incident as a window on the politics of drug policy. The second part offers a more general analysis of why U.S. drug control officials seem to be so threatened by the Dutch example.